Magoola makes Africa’s 100 most influential list

What the report says

Dr. Matthias Magoola, founder and managing director of Dei BioPharma, has been named among Africa’s 100 Most Influential People for 2026, according to The Observer. He received the recognition in Kigali on September 25 from the Accra-based Business Executive Media Group. The organizers said the award reflects his work in biotechnology and pharmaceuticals and its possible contribution to Africa’s capacity to produce more medicines and vaccines locally.

The Observer said the honour also highlights wider expectations around Ugandan pharmaceutical development, especially for patients who rely on imported cancer medicines. Dei BioPharma is developing a large drug and vaccine manufacturing plant in Mattuga, Wakiso district, and Magoola has pointed to affordable cancer treatment, lower dependence on imported vaccines and training African researchers as key goals. The article notes that these are ambitions rather than confirmed outcomes, and it does not establish when products would reach patients or what they would cost.

According to the announcement cited by The Observer, Magoola has filed more than 100 patent applications with the U.S. Patent and Trademark Office covering proposed treatments and vaccines for diseases including cancer, HIV/AIDS, malaria, tuberculosis, diabetes and sickle cell anaemia. The article also mentions a filing for a foot-and-mouth disease vaccine and another for a guided mRNA cancer approach, while cautioning that patent filings do not prove a medicine is safe, effective or approved.

The selection process for the Africa’s 100 Most Influential People list involves research consultants and a 12-member jury. The recognition follows earlier awards cited in the report, including a 2025 Ratna Pharma Award in India and a 2024 International Molecular Biologist Award.